Tissue factor pathway inhibitor as a universal anticoagulant for use in clinical laboratory tests

Tohoku Journal of Experimental Medicine

Volumn 194, Issue 3, 2001, Pages 165-174

  Tsuji, Ryuhei ^a   Tatsumi, Noriyuki ^a   Hino, Masayuki ^a   Nishioka, Takuya ^a   Takubo, Takayuki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anticoagulant; Ethylenediaminetetraacetic acid; Laboratory tests; Tissue factor pathway inhibitor; Whole blood

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; ANTICOAGULANT AGENT; ARGATROBAN; ASPARTATE AMINOTRANSFERASE; ASPARTIC ACID; BILIRUBIN; CHLORINE; CHOLESTEROL; CITRIC ACID THEOPHYLLINE ADENOSINE DIPYRIDAMOLE; CREATININE; CYTOSOL AMINOPEPTIDASE; DIPYRIDAMOLE; EDETIC ACID; EGTAZIC ACID; FLUORIDE SODIUM; GAMMA GLUTAMYLTRANSFERASE; HIRUDIN; ISOPRENE SULFATE; LACTATE DEHYDROGENASE; NITROGEN; POLYMER; POTASSIUM; PROTEIN; PROTEINASE INHIBITOR; SODIUM; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URIC ACID;

ARTICLE; AUTOMATION; BIOCHEMISTRY; BLOOD ANALYSIS; BLOOD CELL; BLOOD CELL COUNT; BLOOD CLOTTING; BLOOD EXAMINATION; BLOOD SAMPLING; CELL STRUCTURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DRUG BLOOD LEVEL; ENVIRONMENTAL TEMPERATURE; EVALUATION; FILM; GIEMSA STAIN; HUMAN; HUMAN CELL; LABORATORY TEST; LEUKOCYTE COUNT; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; THROMBOCYTE COUNT; TURBIDITY;

ANTICOAGULANTS; BLOOD CELL COUNT; BLOOD CELLS; BLOOD COAGULATION; ERYTHROCYTES; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; LIPOPROTEINS; NEUTROPHILS;

EID: 0034753555     PISSN: 00408727     EISSN: None     Source Type: Journal    
DOI: 10.1620/tjem.194.165     Document Type: Article

References (24)

1. Tissue factor pathway inhibitor
2. Technology fundamentals
3. Dream and reality-An introductory case
4. Human recombinant tissue-factor pathway inhibitor prevents the proliferation of cultured human neonatal aortic smooth muscle cells
5. Low-molecular-weight heparin as a multipurpose anticoagulant for laboratory testing
6. The importance of the binding of factor Xa to phospholipids in the inhibitory mechanism of tissue factor pathway inhibitor: The transmembrane and cytoplasmic domains of tissue factor are not essential tissue factor pathway inhibitory
7. Synthetic polymer sulphonated polyisoprene as a universal anticoagulant for laboratory testing
8. Tissue factor pathway inhibitor activity in human plasma. Measurement of lipoprotein-associated and free forms in hyperlipidemia
9. Hirudin as an anticoagulant for both haematology and chemistry tests
10. Argatroban as an anticoagulant for both hematologic and chemical tests
11. DX-9065a, a specific factor Xa inhibitor, as a universal anticoagulant for blood collection tubes
12. The present status of tissue factor pathway inhibitor
13. The role of the tissue factor pathway in initiation of coagulation
14. Analogues of ethylenediamine-tetraacetic acid and sodium fluoride as anticoagulants
15. Tissue factor pathway inhibitor blocks cellular effects of endotoxin by binding to endotoxin and interfering with transfer to CD14
16. Leukocyte differential counting
17. Influence of blood withdrawal and anticoagulant on clotting activity, hematologic data, and certain rheologic measurements
18. Platelet counting and the assessment of platelet function
19. Aminoglycosides prevent and dissociate the aggregation of platelets in patients with EDTA-dependent pseudothrombocytopenia
20. Tissue factor pathway inhibitor (TFPI)-an update
21. Anticoagulant effects of sulphonated polyisoprene
22. A new direction in automated laboratory testing in Japan: Five years of experience with total laboratory automation system management
23. Specimen collection, handling, storage and variability
24. Tissue factor pathway inhibitor: The carboxy-terminus is required for optimal inhibition of factor Xa